KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
288 최은비 박사과정 학생(김미영 교수 실험실) Oncogene 게재(2016.02) / Eun-Bee Choi, a Ph.D candidate in Prof. Mi-Young Kim’s lab published a paper in Oncogene (2016.02) 생명과학과 2016.03.07 12072
287 최유라 학생 21세기 이끌 우수인재상 수상 과사무실 2005.01.27 10821
286 최길주 교수, 제5회 마크로젠 신진과학자상 수상 과사무실 2008.10.13 11400
285 최길주 교수, 정진길 박사 Nature Communications지 논문 게재 (2014. 8) 과사무실 2014.09.12 13008
284 최길주 교수, 이나영 박사 The Plant Cell 게재(2015.08) / Prof. Giltsy Choi and PhD. Nayoung Lee published a paper at The Plant Cell 과사무실 2015.08.19 13097
283 최길주 교수, 김정현 박사과정 학생 The Plant Cell 게재(2016.06) / Prof. Giltsu Choi and Junghyun Kim, a Ph.D. candidate published a paper in The Plant Cell (2016.06) 생명과학과 2016.07.05 12297
282 최길주 교수, The Plant Cell 게재 (2013.12) 과사무실 2013.12.18 12406
281 최길주 교수, PNAS에 논문 게재! 과사무실 2011.01.12 11532
280 최길주 교수, PNAS(P Natl Acad Sci USA) 4월호에 논문 게재 과사무실 2009.04.23 12395
279 최길주 교수, PNAS 에 논문 게재! (2012. 1 online) 과사무실 2012.01.13 10504
278 최길주 교수, Plant Cell 2월호에 논문 게재 과사무실 2009.04.02 11137
277 최길주 교수, KAIST 지정 석좌교수 임명 / Prof. Giltsu Choi is appointed KAIST-chair professor. 생명과학과 2016.03.16 14284
276 최길주 교수 美 광생물학회 학술지 부편집장으로 선임 과사무실 2003.09.22 13027
275 최광욱 교수님 실험실 목정완 박사과정 학생, '2017 페임랩 코리아’ 대상 수상 생명과학과 2017.05.15 19937
274 최광욱 교수, 홍성태 박사 Nature Communications 논문 게재(2016.09) / Prof. Kwang-Wook Choi and Dr. Sung-Tae Hong published a paper in Nature Communications 생명과학과 2016.10.06 11799
273 최광욱 교수, 2014 국내 바이오분야 연구성과 및 뉴스 Top5 선정 / Prof. Kwang-Wook Choi was selected as Top 5 news of 2014 in domestic bio research field 과사무실 2015.01.15 12335
272 초파리의 일주기 리듬에 관여하는 새로운 유전자 발견... 최준호 교수 연구팀 과사무실 2007.07.20 12547
271 주형석 박사와 김은진 학생(강창원 교수 Lab), ‘2009 캠퍼스 특허전략 유니버시아드 대회’에서 기업 CEO상을 수상! 과사무실 2009.12.02 13187
270 조홍석 박사과정 학생, Traveling Award 및 Best Presentation Award 수상 과사무실 2010.07.16 11165
269 조병관교수님_온실가스를 바이오 물질로 전환…미생물 활용한 '인공광합성' 성공 생명과학과 2021.03.10 205
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 17 Next
/ 17